NYSE:NVST Envista (NVST) Stock Price, News & Analysis $22.91 -0.46 (-1.99%) Closing price 03:59 PM EasternExtended Trading$22.94 +0.04 (+0.17%) As of 04:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Envista Stock (NYSE:NVST) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Envista alerts:Sign Up Key Stats Today's Range$22.90▼$23.5150-Day Range$23.07▼$27.8252-Week Range$17.91▼$30.42Volume1.63 million shsAverage Volume3.02 million shsMarket Capitalization$3.73 billionP/E Ratio55.87Dividend YieldN/APrice Target$28.83Consensus RatingHold Company Overview Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software. Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments. Its integrated approach enables dental professionals to access consumables, equipment and digital workflow tools through a unified platform, helping to streamline procedures and enhance patient care. The company supports research and development initiatives aimed at advancing digital dentistry and improving clinical outcomes. Envista was established in July 2019 following its spin-off from Danaher Corporation, bringing together decades of dental industry expertise under a dedicated corporate structure. Since its inception, Envista has expanded its geographic reach and invested in strategic partnerships to drive innovation and market penetration. The company’s leadership team, led by a chief executive officer and experienced executives in operations, marketing and research, focuses on long-term growth through product development, acquisitions and operational excellence.AI Generated. May Contain Errors. Read More Envista Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks54th Percentile Overall ScoreNVST MarketRank™: Envista scored higher than 54% of companies evaluated by MarketBeat, and ranked 551st out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.2 / 5Analyst RatingHold Consensus RatingEnvista has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 6 buy ratings, 9 hold ratings, and no sell ratings.Upside PotentialEnvista has a consensus price target of $28.83, representing about 25.7% upside from its current price of $22.95.Amount of Analyst CoverageEnvista has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Envista's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth9.09% Earnings GrowthEarnings for Envista are expected to grow by 9.09% in the coming year, from $1.43 to $1.56 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Envista is 56.54, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.28.Price to Earnings Ratio vs. SectorThe P/E ratio of Envista is 56.54, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.16.Price to Earnings Growth RatioEnvista has a PEG Ratio of 1.48. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioEnvista has a P/B Ratio of 1.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Envista's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.08% of the float of Envista has been sold short.Short Interest Ratio / Days to CoverEnvista has a short interest ratio ("days to cover") of 2.73, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Envista has recently increased by 20.88%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEnvista does not currently pay a dividend.Dividend GrowthEnvista does not have a long track record of dividend growth. News and Social Media1.3 / 5News SentimentN/A Search Interest1 people have searched for NVST on MarketBeat in the last 30 days. MarketBeat Follows2 people have added Envista to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Envista insiders have not sold or bought any company stock.Percentage Held by Insiders0.99% of the stock of Envista is held by insiders.Percentage Held by InstitutionsEnvista has minimal institutional ownership at this time.Read more about Envista's insider trading history. Receive NVST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Envista and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NVST Stock News HeadlinesThe Bull Case For Envista Holdings (NVST) Could Change Following New Small-Cap Fund Backing And Margin FocusMay 23, 2026 | finance.yahoo.comEnvista Shareholders Back Board, Pay Practices, and AuditorMay 21, 2026 | tipranks.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.June 2 at 1:00 AM | InvestorPlace (Ad)Aristotle Small Cap Equity Fund Picked Envista Holdings (NVST) Citing Varied Growth SignalsMay 21, 2026 | insidermonkey.comEnvista Holdings Corp (NVST) Shares Surge 3.1% -- What GF Score of 82 Tells InvestorsMay 21, 2026 | gurufocus.com5 Insightful Analyst Questions From Envista’s Q1 Earnings CallMay 17, 2026 | finance.yahoo.comNVST Q1 Deep Dive: Strong Revenue Growth, Market Cautious on Macro and TariffsMay 14, 2026 | finance.yahoo.comAmericans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to WinMay 13, 2026 | 247wallst.comSee More Headlines NVST Stock Analysis - Frequently Asked Questions How have NVST shares performed this year? Envista's stock was trading at $21.72 at the beginning of 2026. Since then, NVST shares have increased by 5.6% and is now trading at $22.9450. How were Envista's earnings last quarter? Envista Holdings Corporation (NYSE:NVST) announced its earnings results on Wednesday, May, 6th. The company reported $0.36 earnings per share for the quarter, topping analysts' consensus estimates of $0.31 by $0.05. The company's revenue was up 14.4% on a year-over-year basis. Read the conference call transcript. When did Envista IPO? Envista (NVST) raised $602 million in an initial public offering on Wednesday, September 18th 2019. The company issued 26,768,000 shares at a price of $21.00-$24.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley served as the underwriters for the IPO and Baird, Evercore ISI, Jefferies, BofA Merrill Lynch, Credit Suisse, Stifel and William Blair were co-managers. Who are Envista's major shareholders? Top institutional investors of Envista include Dimensional Fund Advisors LP (6.00%), Arrowstreet Capital Limited Partnership (1.76%), Quantinno Capital Management LP (1.66%) and Pzena Investment Management LLC (0.98%). Insiders that own company stock include Amir Aghdaei, Eric Conley, Mark E Nance, Mischa Reis, Eric D Hammes and Stephen Keller. View institutional ownership trends. How do I buy shares of Envista? Shares of NVST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Envista own? Based on aggregate information from My MarketBeat watchlists, some other companies that Envista investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH), The RMR Group (RMR) and AUO (AUOTY). Company Calendar Last Earnings5/06/2026Today6/02/2026Next Earnings (Estimated)8/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (3w+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 For the last 3 weeks, NVST's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED PRODUCTS Sub-IndustryMedical Equipment Current SymbolNYSE:NVST CIK1757073 Webwww.envistaco.com Phone714-817-7000Fax714-817-5450Employees12,000Year Founded2018Price Target and Rating Average Price Target for Envista$28.83 High Price Target$35.00 Low Price Target$21.00 Potential Upside/Downside+25.9%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage15 Analysts Profitability EPS (Trailing Twelve Months)$0.41 Trailing P/E Ratio56.54 Forward P/E Ratio16.02 P/E Growth1.48Net Income$47 million Net Margins2.41% Pretax Margin7.14% Return on Equity7.11% Return on Assets3.91% Debt Debt-to-Equity Ratio0.47 Current Ratio2.44 Quick Ratio2.06 Sales & Book Value Annual Sales$2.81 billion Price / Sales1.33 Cash Flow$2.11 per share Price / Cash Flow10.85 Book Value$18.89 per share Price / Book1.21Miscellaneous Outstanding Shares162,728,000Free Float161,117,000Market Cap$3.73 billion OptionableOptionable Beta0.88 Social Links 10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report This page (NYSE:NVST) was last updated on 6/2/2026 by MarketBeat.com Staff. From Our PartnersHow to claim a stake in SpaceX before the June 12 IPOSpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...Brownstone Research | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredPresident Trump just sparked a stock market MELT UPThe real reason Musk, Huang, Cook, and Fink just flew to Beijing Last week, the CEOs of Nvidia, Apple, Spac...Stansberry Research | SponsoredGiving “2022 pre-ChatGPT” vibes (but 10x bigger)When ChatGPT launched in 2022, Nvidia surged 1,800% over three years. Now, Nvidia's CEO suggests July 22nd cou...StocksToTrade | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredThe roadshow starts Monday. This stock isn't ready.The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envista Holdings Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Envista With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
